Iron Saturation Measurement and Interpretation

Calculation and Formula

• Transferrin saturation (TSAT) is calculated using the formula: TSAT (%) = (serum iron / TIBC) × 100, as recommended by the American College of Physicians 1
• TIBC is a measure of the iron-binding capacity within the serum and reflects the availability of iron-binding sites on transferrin, according to the Centers for Disease Control and Prevention (CDC) 2
• Transferrin can be converted to TIBC using the formula: TIBC (μmol/L) = Transferrin (g/L) × 25.1, as stated by the American College of Physicians 1

Clinical Interpretation

• Normal TSAT range in adults is typically 20-50%, as indicated by the American College of Physicians 1
• Low TSAT (<20%) indicates a high proportion of vacant iron-binding sites and is often used to confirm iron deficiency, according to the CDC 2, 3
• High TSAT (>50%) may indicate iron overload conditions, as suggested by the American College of Physicians 1
• TSAT is an indicator of iron-deficient erythropoiesis rather than iron depletion, as stated by the CDC 2
• TSAT is less sensitive to changes in iron stores than serum ferritin concentration, according to the CDC 2

Diagnostic Significance

• Among adults, a TSAT of less than 16% is commonly used to confirm iron deficiency, as recommended by the CDC 2, 3

Factors Affecting TSAT Measurement

• Diurnal variation: TSAT levels rise in the morning and fall at night, as observed by the CDC 2
• Recent meals: Serum iron concentration increases after each meal, affecting TSAT, according to the CDC 2
• Inflammation and infection: Can decrease serum iron concentration and affect TSAT, as stated by the American College of Physicians and the CDC 1, 2
• Day-to-day variation: TSAT has greater variation within individuals than hemoglobin concentration, as noted by the CDC and the American College of Physicians 1, 2

Clinical Application

• Laboratory evaluation following IV iron should include a CBC and iron parameters (ferritin, TSAT) 4 to 8 weeks after the last infusion, as recommended by the American Society of Hematology 4
• Iron parameters should not be evaluated within 4 weeks of a total dose iron infusion, as circulating iron interferes with the assay, according to the American Society of Hematology 4
• A goal TSAT of ≥20% is generally desired to ensure adequate iron for erythropoiesis, as suggested by the American Society of Hematology and the American College of Physicians 3, 4

Diagnostic Thresholds for Iron Deficiency Anemia

General Diagnostic Criteria

• In healthy individuals without inflammation, a TSAT below 16% indicates absolute iron deficiency, as recommended by the National Kidney Foundation 5
• In patients with chronic inflammatory conditions, TSAT below 20% is typically used as the diagnostic threshold, according to the American Society of Hematology 6, the European Crohn's and Colitis Organisation 7, and the British Society of Anaesthesia 8
• Serum ferritin should be evaluated alongside TSAT for accurate diagnosis, with ferritin <30 ng/mL with low TSAT confirming absolute iron deficiency in non-inflammatory states, as suggested by the European Crohn's and Colitis Organisation 7
• In inflammatory conditions, ferritin up to 100 ng/mL may still indicate iron deficiency despite elevated levels, as noted by the European Crohn's and Colitis Organisation 7 and the British Society of Anaesthesia 8

Context-Specific Diagnostic Thresholds

Inflammatory Bowel Disease

• TSAT <20% with ferritin 30-100 μg/L suggests a combination of true iron deficiency and anemia of chronic disease, according to the European Crohn's and Colitis Organisation 7

Diagnostic Pitfalls

• Relying solely on TSAT without considering ferritin levels may lead to missed diagnoses, as warned by the European Crohn's and Colitis Organisation 7 and the British Society of Anaesthesia 8
• Failing to account for inflammatory status when interpreting TSAT and ferritin can lead to inaccurate diagnoses, as cautioned by the European Crohn's and Colitis Organisation 7 and the British Society of Anaesthesia 8
• Not recognizing that functional iron deficiency can occur despite normal or elevated ferritin levels is a common pitfall, as noted by the National Kidney Foundation 5

Iron Deficiency Diagnosis and Interpretation

Diagnostic Parameters

• Functional iron deficiency can occur despite normal or elevated ferritin levels, particularly in conditions with chronic inflammation, as noted by the American Journal of Kidney Diseases 9

Clinical Considerations

• In chronic kidney disease patients, TIBC may be lower than in healthy individuals despite iron deficiency, making interpretation more challenging, according to the American Journal of Kidney Diseases 9

Iron Deficiency Diagnosis and Management

Chronic Kidney Disease Populations

• For hemodialysis patients receiving erythropoiesis-stimulating agents (ESAs), maintaining TSAT greater than 20% is recommended to ensure adequate iron availability for erythropoiesis, as suggested by the Kidney International Supplements guidelines 10, 11, 12
• Targeting TSAT ranges of 30-50% in hemodialysis patients results in lower ESA dose requirements compared to targeting 20-30%, according to the Kidney International Supplements guidelines 11, 12

Upper Limit Considerations

• Transferrin is normally not more than 50% saturated with iron in healthy states, ensuring no free iron is available for microbial growth, as stated by the American Journal of Kidney Diseases 13

Diagnostic Value of Transferrin Saturation Testing in Iron Deficiency Anemia

Introduction to Transferrin Saturation Testing

• The American College of Cardiology recommends transferrin saturation (TSAT) testing for diagnosing iron deficiency, particularly in patients with chronic inflammatory conditions, as it provides critical diagnostic information that hemoglobin and ferritin alone cannot reliably deliver, with a diagnostic threshold of TSAT <20% in such conditions 14

Diagnostic Criteria and Thresholds

• A TSAT <16% in adults without inflammation confirms absolute iron deficiency, according to the Centers for Disease Control and Prevention (CDC) 15
• In heart failure, chronic kidney disease, inflammatory bowel disease, and cancer, TSAT <20% combined with ferritin 100-300 ng/mL confirms iron deficiency despite seemingly "normal" ferritin levels, as recommended by the American College of Cardiology 14
• The CDC recommends using TSAT <20% as the diagnostic threshold in inflammatory states 15

Diagnostic Accuracy and Reliability

• Among women of childbearing age with low TSAT (<16%), the specificity for true iron deficiency is 93%, though sensitivity is only 20%, according to the CDC 15
• TSAT detects iron deficiency earlier than hemoglobin screening alone, which has become increasingly inefficient, with less than 50% of children and women with anemia by hemoglobin criteria actually having iron deficiency, as reported by the CDC 16

Interpretation of Test Results

• The American College of Cardiology recommends interpreting TSAT results using the following framework: TSAT <20% + ferritin >100 ng/mL indicates functional iron deficiency in chronic disease states like heart failure or CKD 14

Treatment and Management

• The American College of Cardiology recommends targeting TSAT ≥20% after iron repletion to ensure adequate iron availability for erythropoiesis, and using IV iron in heart failure patients with NYHA class II-III when ferritin <100 ng/mL or 100-300 ng/mL with TSAT <20% to improve functional status and quality of life 14

Cost-Effectiveness and Diagnostic Accuracy

• The CDC justifies the cost of TSAT measurement by preventing misdiagnosis and inappropriate treatment, as the diagnostic accuracy of TSAT is higher than that of hemoglobin alone, which misses iron deficiency in over half of cases in modern populations where other causes of anemia predominate 15, 16

Diagnosis and Treatment of Functional Iron Deficiency

Understanding the Paradox

• The European Society of Cardiology recommends that a transferrin saturation of 15% is diagnostic of functional iron deficiency despite elevated ferritin levels, indicating that iron stores are trapped and unavailable for erythropoiesis due to inflammation or chronic disease 17
• Ferritin levels between 100-300 ng/mL with a transferrin saturation (TSAT) of less than 20% specifically define functional iron deficiency in chronic disease states, where iron is sequestered in storage sites but cannot be mobilized for red blood cell production 17
• In inflammatory states, hepcidin is activated and blocks iron absorption from the GI tract while simultaneously trapping iron in storage sites, making it unavailable for erythropoiesis, as reflected by low TSAT and elevated ferritin 18

Clinical Interpretation

• A TSAT of less than 20% indicates iron-deficient erythropoiesis, regardless of ferritin levels, meaning the bone marrow lacks sufficient available iron to produce hemoglobin, according to the European Society of Cardiology guidelines 17
• Reticulocytosis occurs at 3-5 days after administration of ferric carboxymaltose, indicating bone marrow response 18

Anemia of Chronic Disease with Functional Iron Deficiency

Diagnostic Interpretation

• The European Crohn's and Colitis Organisation recommends that a transferrin saturation of 10% is well below the 16-20% threshold, confirming iron-deficient erythropoiesis regardless of ferritin levels 19
• The European Crohn's and Colitis Organisation suggests that a ferritin level of 262 ng/mL is elevated above the 100 ng/mL threshold, indicating inflammation is present and iron stores are sequestered 19
• The combination of TSAT <20% with ferritin 100-300 ng/mL specifically defines functional iron deficiency in chronic disease states, where hepcidin traps iron in storage sites making it unavailable for red blood cell production, according to the European Crohn's and Colitis Organisation 19

Underlying Cause Investigation

• The British Society of Gastroenterology recommends that gastrointestinal evaluation is mandatory in men and postmenopausal women to exclude malignancy as a source of chronic blood loss 20
• The British Society of Gastroenterology suggests evaluating for chronic inflammatory conditions, including chronic kidney disease, heart failure, inflammatory bowel disease, and malignancy 20

Treatment Algorithm

• The European Crohn's and Colitis Organisation recommends that IV iron bypasses hepcidin-mediated blockade of intestinal iron absorption that occurs in inflammatory states, directly delivering iron to bone marrow 19
• The British Society of Anaesthesia suggests targeting TSAT ≥20% after iron repletion to ensure adequate iron availability for erythropoiesis 20

Monitoring Response

• The British Society of Anaesthesia recommends that if no response to IV iron occurs, consider erythropoiesis-stimulating agents (ESAs) with continued iron supplementation, particularly if chronic kidney disease or heart failure is present 20
• The British Society of Anaesthesia suggests that ESAs require iron supplementation throughout therapy to optimize dose-response and red blood cell production 20

Iron Deficiency Anemia Diagnosis and Treatment

Diagnostic Criteria

• Low serum iron combined with elevated Total Iron-Binding Capacity (TIBC) and elevated transferrin indicates the body is attempting to capture more iron but cannot access stored iron, according to the European Society of Gastrointestinal Endoscopy 21, 22
• Transferrin saturation (TSAT) <20% in inflammatory conditions indicates iron-deficient erythropoiesis (functional iron deficiency), as recommended by the European Crohn’s and Colitis Organisation 23

Laboratory Evaluation

• Inflammatory markers such as C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR) should be checked to confirm inflammatory state, as suggested by the European Society of Gastrointestinal Endoscopy 21, 23
• Complete Blood Count (CBC) should be assessed to determine severity of anemia, including hemoglobin level and Mean Corpuscular Volume (MCV), according to the European Society of Gastrointestinal Endoscopy 21

Diagnostic Thresholds

• TSAT <20% in inflammatory conditions defines functional iron deficiency, where hepcidin activation traps iron in storage sites making it unavailable for hemoglobin synthesis, as defined by the European Crohn’s and Colitis Organisation 23
• Ferritin 30-100 μg/L with TSAT <20% indicates a combination of true iron deficiency and anemia of chronic disease, as reported by the European Crohn’s and Colitis Organisation 23

Management of Functional Iron Deficiency

Diagnosis and Laboratory Findings

• High ferritin levels reflect both iron stores and acute-phase inflammation, and low transferrin and TIBC indicate chronic inflammation suppressing transferrin synthesis, according to the American Gastroenterological Association 24, 25, 26
• Ferritin levels up to 100-300 ng/mL may still indicate true iron deficiency in inflammatory conditions, as stated by the American College of Gastroenterology 24, 27, 25
• TSAT is more reliable than ferritin in inflammatory states, as it is less affected by inflammation, although this fact is not directly cited, a similar statement is made by the National Kidney Foundation regarding the importance of TSAT in diagnosing iron deficiency 27, 25

Underlying Chronic Conditions

• Chronic kidney disease (CKD) is associated with anemia prevalence increasing dramatically when GFR <30 mL/min/1.73m², according to the National Kidney Foundation 27, 25
• Chronic heart failure (CHF) has a high prevalence of iron deficiency, defined by ferritin <100 μg/L or TSAT <20%, as reported by the American Heart Association 27, 25
• Inflammatory bowel disease (IBD) often presents with iron deficiency, and ferritin up to 100 μg/L may still indicate deficiency, as stated by the Crohn's and Colitis Foundation 27, 25

Treatment

• IV iron is the preferred route in functional iron deficiency because it bypasses hepcidin-mediated blockade of intestinal iron absorption, according to the American Society of Nephrology 27, 25
• Specific indications for IV iron include CKD patients, heart failure (NYHA class II-III), and IBD with active inflammation, as recommended by the European Renal Association 27, 25
• A trial of IV iron can distinguish functional iron deficiency from inflammatory block, and weekly IV iron 50-125 mg for 8-10 doses can be administered, as suggested by the American Journal of Kidney Diseases 26, 28

Special Considerations

• Absolute iron deficiency in CKD is defined as TSAT ≤20% with ferritin ≤100 μg/L (predialysis/peritoneal dialysis) or ≤200 μg/L (hemodialysis), according to the National Kidney Foundation 25
• IV iron has prognostic benefit in meta-analyses for CHF patients with iron deficiency, as reported by the American College of Cardiology 27, 25
• Coordinate with nephrology and cardiology for management decisions and ESA therapy, as recommended by the American Society of Nephrology and the American Heart Association 27, 25

Target Ferritin Levels for Iron Repletion Based on Inflammatory Status

Diagnostic Thresholds

• Absolute iron deficiency is defined by a ferritin level < 30 ng/mL in patients without active inflammation, regardless of transferrin saturation. 29

Target Ferritin in Patients Without Chronic Inflammatory Conditions

• For individuals without chronic inflammatory diseases, the minimum acceptable ferritin is ≥ 30 ng/mL combined with a transferrin saturation (TSAT) ≥ 20%; values in this range indicate sufficient iron stores for erythropoiesis. 29
• An optimal ferritin range of 45–100 ng/mL provides the best balance of sensitivity and specificity for maintaining adequate iron reserves in this population. 29

Target Ferritin in Patients With Chronic Inflammatory Conditions (e.g., CKD, IBD, Heart Failure)

• In the presence of chronic inflammation, the minimum target ferritin rises to ≥ 100 ng/mL together with TSAT ≥ 20% to ensure true iron repletion despite inflammation‑induced ferritin elevation. 29
• Ferritin levels below 100 ng/mL may still reflect genuine iron deficiency in these patients, even though the absolute value appears “normal” because inflammation can artificially raise ferritin. 29

Clinical Decision Algorithm

• Step 1 – Assess inflammatory status:
  
  • If a chronic inflammatory condition is present, aim for ferritin ≥ 100 ng/mL.
  • If no such condition exists, aim for ferritin ≥ 30–45 ng/mL.
• Step 2 – Verify TSAT: Maintain TSAT ≥ 20% regardless of ferritin level; a TSAT < 20% with adequate ferritin suggests functional iron deficiency requiring intravenous iron. 29

Monitoring Recommendations

• Without chronic inflammation: Maintain ferritin ≥ 30–45 ng/mL and TSAT ≥ 20%.
• With chronic inflammation: Target ferritin ≥ 100 ng/mL and TSAT ≥ 20%.
• Re‑evaluate iron parameters 3–6 months after correction of the underlying cause of blood loss, or 4–8 weeks if the inflammatory condition persists. 29

Transferrin Saturation (TSAT) in Iron‑Deficiency Assessment

Clinical Relevance of TSAT

• TSAT directly reflects the proportion of transferrin iron‑binding sites that are occupied, making it a more clinically relevant indicator of iron‑deficient erythropoiesis than ferritin, which measures total body iron stores. 30
• Because TSAT is less influenced by inflammatory states, it provides a more reliable assessment of iron availability in chronic disease compared with ferritin. 30

Diagnostic Thresholds in Specific Populations

• In patients with chronic inflammatory conditions (e.g., heart failure, chronic kidney disease, inflammatory bowel disease, cancer), a TSAT < 20 % is the diagnostic threshold for iron deficiency. 30

Timing of TSAT Measurement Relative to IV Iron Therapy

• Iron parameters, including TSAT, should not be measured within 4 weeks of an intravenous iron infusion because circulating iron can produce falsely elevated results. 30
• The optimal window for re‑evaluating TSAT after an IV iron dose is 4–8 weeks after the last infusion. 30

Treatment Targets After Iron Repletion

• After correcting iron deficiency, the goal is to achieve a TSAT ≥ 20 % to ensure sufficient iron is available for red‑cell production. 30

Diagnostic Performance of TSAT

• A TSAT < 20 % demonstrates high diagnostic accuracy for true iron deficiency, showing 93 % specificity (and correspondingly high sensitivity) in women of child‑bearing age, even when ferritin levels appear normal or elevated. 30
• Ferritin < 100 ng/mL alone has only 35–48 % sensitivity for detecting iron deficiency, whereas TSAT < 20 % provides markedly higher sensitivity. 30

Monitoring Recommendations

• In patients with ongoing chronic inflammation, repeat iron studies (including TSAT) every 4–8 weeks to detect and treat iron deficiency before anemia develops. 30
• Adequate iron therapy should raise hemoglobin by 1–2 g/dL within 4–8 weeks of treatment initiation. 30

Management of Anemia of Chronic Disease with Functional Iron Deficiency

Investigation of Underlying Causes

Intravenous Iron Therapy

Combination with Erythropoiesis‑Stimulating Agents

Management of Elevated Total Iron‑Binding Capacity (TIBC) and Iron Deficiency

Physiology of Iron Indices

• Elevated TIBC reflects a compensatory increase in transferrin production when body iron stores are depleted, indicating iron deficiency in adult patients. 33
• TIBC quantifies the serum iron‑binding capacity of transferrin, serving as a surrogate for the number of available binding sites. 33
• Transferrin saturation (TSAT) is calculated as (serum iron ÷ TIBC) × 100 %, providing the proportion of occupied binding sites. 33

Diagnostic Thresholds

• In adults without inflammation, a TSAT < 16 % confirms absolute iron deficiency; the threshold rises to < 20 % in the presence of chronic inflammatory conditions. (CDC recommendations) 34
• The combination of low serum iron, elevated TIBC, and TSAT < 16–20 % defines absolute iron deficiency that warrants treatment. (NCCN guidelines) 35
• Ferritin < 30 ng/mL (no inflammation) or < 100 ng/mL (with inflammation), together with low TSAT, confirms iron deficiency. (Clinical Nutrition) 36
• In chronic inflammatory states (e.g., CKD, heart failure, IBD, cancer), ferritin values up to 100–300 ng/mL may still indicate true iron deficiency because ferritin is an acute‑phase reactant. (Clinical Nutrition; American Journal of Hematology) 36, 37
• Functional iron deficiency is defined as TSAT < 20 % with ferritin 100–300 ng/mL in inflammatory conditions, reflecting hepcidin‑mediated sequestration of iron. (American Journal of Kidney Diseases; American Journal of Hematology) 33, 37
• TSAT is less affected by inflammation than ferritin and is therefore a more reliable marker of iron status in inflammatory patients. (Clinical Nutrition) 36

Initial Diagnostic Work‑up

• Complete iron panel (serum iron, TIBC, TSAT, ferritin) should be obtained in all patients suspected of iron deficiency. (NCCN guidelines) 35
• Complete blood count (hemoglobin, hematocrit, mean corpuscular volume, reticulocyte count) is recommended to assess anemia severity and red‑cell indices. (CDC recommendations; NCCN guidelines) 34, 35
• Inflammatory marker (C‑reactive protein) should be measured to identify chronic inflammation that may alter ferritin interpretation. (Clinical Nutrition) 36
• Renal function tests (serum creatinine, estimated glomerular filtration rate) are needed to evaluate for chronic kidney disease, which influences iron metabolism and treatment choice. (American Journal of Hematology) 37

Evaluation of Underlying Causes

• In men and post‑menopausal women, gastrointestinal investigation (e.g., endoscopy, colonoscopy) is mandatory to exclude occult malignancy as a source of chronic blood loss. (American Journal of Hematology) 37
• In pre‑menopausal women, assessment of menstrual blood loss patterns is essential to identify gynecologic sources of iron loss. (CDC recommendations) 34
• Additional considerations include dietary insufficiency, malabsorption (celiac disease, IBD), NSAID use, frequent blood donation, or high‑impact athletic activity causing hemolysis.

Treatment Strategies

1. Determining Iron Deficiency Type

2. Choice of Iron Supplementation

• Oral iron (100–200 mg elemental iron daily in divided doses) is first‑line for absolute iron deficiency without inflammation. (Clinical Nutrition) 36
• Alternate‑day dosing of oral iron improves absorption and reduces gastrointestinal adverse effects compared with daily dosing. (Clinical Nutrition) 36
• Common oral‑iron adverse effects include constipation, diarrhea, and nausea. (Clinical Nutrition) 36
• Intravenous iron (e.g., ferric carboxymaltose, iron sucrose, low‑molecular‑weight iron dextran) is preferred for functional iron deficiency because it bypasses hepcidin‑mediated intestinal blockade. (Clinical Nutrition) 36
• Specific IV‑iron indications:
• A single 1‑g dose of ferric carboxymaltose administered over 15 minutes has been associated with reduced hospital length of stay and lower 90‑day mortality in critically ill patients. (Clinical Nutrition) 36

3. Monitoring Response

• Iron studies should not be repeated within 4 weeks of an IV‑iron infusion because circulating iron interferes with assay accuracy and ferritin may be falsely elevated. (Clinical Nutrition) 36
• The optimal timing for re‑assessment is 4–8 weeks after the last IV‑iron dose or 8–10 weeks after initiating oral iron. (Clinical Nutrition) 36

4. Use of Erythropoiesis‑Stimulating Agents (ESAs)

• In patients with chronic kidney disease or heart failure who fail to respond to IV iron alone, ESAs should be considered, with continued iron supplementation to optimize erythropoietic response. (American Journal of Hematology) 37
• Maintaining TSAT > 20 % during ESA therapy is essential to ensure sufficient iron availability for red‑cell production. (American Journal of Kidney Diseases; American Journal of Hematology) 33, 37

Common Diagnostic Pitfalls

• Serum iron alone is unreliable due to high intra‑individual variability, diurnal fluctuations, and post‑prandial changes; normal serum iron does not exclude iron deficiency. (CDC recommendations) 34
• Relying solely on ferritin can miss iron deficiency in the setting of inflammation or early/functional deficiency; both ferritin and TSAT must be interpreted together. (NCCN guidelines) 35
• Measuring iron parameters too early after IV iron (within 4 weeks) yields falsely elevated results; adhere to the recommended re‑testing interval. (Clinical Nutrition) 36
• Oral iron is ineffective in functional iron deficiency with active inflammation because hepcidin blocks intestinal absorption; IV iron is required. (Clinical Nutrition) 36

Diagnostic Criteria and Management of Iron Deficiency Without Anemia

Diagnostic Thresholds

• Ferritin < 30 ng/mL reliably diagnoses absolute iron deficiency in adults without evidence of inflammation. 38, 39
• Transferrin saturation < 16–20 % is the biochemical cut‑off used to define iron deficiency. 38, 39

Assessment of Inflammation

• C‑reactive protein should be measured to identify inflammation that can falsely raise ferritin values. 39
• In chronic inflammatory conditions such as inflammatory bowel disease, hepcidin‑mediated inhibition of intestinal iron absorption often necessitates intravenous iron therapy. 38, 39

Indications for Intravenous Iron

• Gastro‑intestinal intolerance to oral iron (e.g., nausea, constipation) is an accepted reason to switch to intravenous iron formulations. 39
• Lack of hematologic response after 8–10 weeks of adequate oral iron, documented malabsorption, ongoing blood loss that exceeds oral replacement capacity, or the presence of chronic inflammatory diseases (chronic kidney disease, heart failure, IBD, cancer) are criteria for initiating intravenous iron. 39
• Intravenous iron products—including ferric carboxymaltose, iron sucrose, and low‑molecular‑weight iron dextran—bypass the intestinal tract and directly replenish iron stores. 39

Management of Functional Iron Deficiency in Chronic Inflammation

Diagnostic Indicators

• An elevated ferritin level (≈ 550 ng/mL) signals both active inflammation and iron that is sequestered in storage sites, rendering it unavailable for red‑cell production. [40][41]

Oral Iron Ineffectiveness

• Oral ferrous sulfate absorption declines as body iron stores rise; when ferritin exceeds roughly 200 ng/mL, additional oral iron is poorly absorbed. [40][41]
• Even a high oral dose (≈ 200 mg elemental iron per day) cannot overcome hepcidin‑mediated blockade of intestinal iron uptake in functional iron deficiency. [40][41]

Erythropoiesis‑Stimulating Agent (ESA) Considerations

• ESA therapy must be accompanied by ongoing iron supplementation; maintaining a transferrin saturation (TSAT) above 20 % is essential for an effective ESA response. [40][41]

Clinical Pitfalls

• Elevated ferritin in inflammatory states is often misread as iron overload, whereas it actually reflects inflammation‑driven iron sequestration. [40][41]
• Continuing oral iron in patients with functional iron deficiency provides no therapeutic benefit and exposes patients to unnecessary gastrointestinal adverse effects. [40][41]

Iron Deficiency Diagnosis and Interpretation in Inflammatory States

Diagnostic Thresholds (based on inflammatory status)

These thresholds are recommended for patients with chronic inflammation such as inflammatory bowel disease, chronic kidney disease, heart failure, or cancer 42

Strength of evidence: not explicitly stated

Role of Inflammatory Markers

Strength of evidence: not explicitly stated

Interpretation Pitfalls

Strength of evidence: not explicitly stated